Technology Commercialization Panel
The Technology Commercialization Panel (TCP) is a group of market experts, successful entrepreneurs, and experienced investors that Tech Transfer meets with on a bimonthly basis. The TCP provides Tech Transfer with valuable commercial feedback on APL intellectual property and industry contacts to improve the impact of our commercialization efforts.
With an extensive record in the field of technology, Irfan Ali has a unique combination of executive management, technical, and marketing skills. A professed technologist, he has a passion for bringing new, innovative technology to the market in the form of products and solutions that address complex, contemporary problems. Prior to joining ARC, Irfan was President and CEO of Lambda OpticalSystems, a late-stage, venture-backed start-up building high-end optical networking equipment. Before Lambda, he was President of CommWorks Corporation, a 3Com company. Irfan received an M.S. in electrical engineering and an M.B.A. from Southern Methodist University. He was also a founding member of the ATM Forum.
Stephen Auvil is the Senior Vice President for Technology Transfer and Commercialization at the Maryland Technology Development Corporation (TEDCO). In this role, he is responsible for overseeing TEDCO’s funding programs. He is also responsible for other programs that foster the transfer of technologies from universities and federal laboratories into the commercial sector. Stephen, who was one of the architects of the University of Maryland, Baltimore County (UBMC) programs ACTiVATE® and INNoVATE™, served as a co-principal investigator on the National Science Foundation grants that supported these programs.
Chuck Cullen is an investment professional and is responsible for all financial, accounting, and administrative functions for the Grotech funds as Chief Financial Officer. Chuck’s investment activities focus on e-commerce, enterprise software, security, and health care IT. Chuck is active on several portfolio company boards, including buySAFE, Biotix, Healthcare Interactive, OpenQ, and WiserTogether. He previously served on the boards of MEDecision, Brandywine Senior Care, Sagittarius Brands, and Entek. He has also worked closely with management at HealthScribe and First Service Networks.
Steve Falk is the Chief Engineer for Maternal Infant Care at GE Healthcare. He has been with the company for 28 years in a variety of roles, including Senior Engineer, Engineering Manager, Lead Program Engineer, Engineering Director, Chief Technology Officer, and Chief Engineer. Steve has been integrally involved with all phases of product development, including voice of customer, business development, business model generation, design, verification, validation, and production transfer. He also serves as the Patent Evaluation Board leader. Steve has a bachelor’s degree in engineering from the University of Pennsylvania and a master’s degree in engineering from The Catholic University of America.
Dr. Chris Geddes has extensive experience in fluorescence spectroscopy, particularly in fluorescence sensing and metal-fluorophore interactions. Chris is internationally known in fluorescence and plasmonics, and the development of the metal-enhanced fluorescence (MEF) and related plasmon-fluorescence technologies is widely attributed to his laboratory. He is Director of the Institute of Fluorescence, a department within the University of Maryland, Baltimore County (UBMC), which focuses on the nano-bio-technological applications of fluorescence. Chris holds more than 100 patents in the fields of fluorescence and plasmonics.
Jim Goepel is Fathom Cyber’s CEO and General Counsel. He worked in a variety of technical roles for large corporations, start-ups, and Congress before attending law school. In his legal career, Jim worked for several years as an outside attorney and patent agent for a large law firm, where he advised individuals, start-ups, and Fortune 100 corporations on a wide range of legal matters. He is active in defining the technical attributes of Fathom Cyber’s flagship offerings, ensures that the company’s intellectual property is well protected, and provides legal guidance in other areas as well.
Dr. Albine Martin has 20 years of operating and product commercialization experience within three three public companies representing the biotechnology, diagnostics, and life sciences sector. She provided translational leadership to advance technologies from bench to market during her role as Entrepreneur in Residence at Johns Hopkins University and BioHealth Innovation. She has served as Chief Operating Officer of Precision Biologics (a clinical-stage oncology company with a companion diagnostic), where she formulated a virtual business model and operationalized a network to advance biologics from preclinical to Phase 2 trials. Albine holds a Ph.D. from the University of Maryland, served as a Staff Fellow at the National Institutes of Health, holds a Certificate of Financial Management from Cornell University, and is a graduate of the Program on Leadership and Strategy in Pharmaceuticals and Biotech at Harvard Business School.
Jay Pasricha received his training in gastroenterology at Johns Hopkins Hospital. In August 2007, he was appointed as Chief of Gastroenterology at Stanford University of Medicine, a position he held until assuming his current position back at Johns Hopkins in July 2012. Jay has served on the National Commission on Digestive Diseases, which was appointed by Congress to provide a “road map” for progress in gastrointestinal disorders. He is also the founding chair of the Center for Gastrointestinal Innovation and Technology, a body created by the American Gastroenterological Association. Jay holds more than 50 patents and has cofounded several companies within both the medtech and biotech GI space, including Apollo Endosurgery, Enterastim, First Aid Shot Therapeutics (FAST), Neurogastrx, Orphomed, and Glyscend.
Rebecca Ranich is an energy industry executive with deep roots in capital intense energy supply and demand infrastructure and energy technologies. Over her career, she has led transformational business initiatives, forged global strategic alliances, and led new market ventures in energy and infrastructure sectors. She is a member of the Supervisory Board for Uniper SE and also serves on the advisory board of Yet Analytics, Inc.
Gus Simiao is an Entrepreneur in Residence at Data Point Capital. His areas of interest include artificial intelligence, robotics, cybersecurity, mobility, and enterprise software. Most recently, Gus was Principal at CEVG, an angel investment group focused on early-stage companies. Previously, he was CEO of Electric Field Solutions, a spin-out from the University of Michigan that developed and marketed an innovative electric field sensor. Before Electric Field Solutions, Gus was CEO of Vortex Hydro Energy, which developed an innovative technology also licensed from the University of Michigan. He raised $4M to fund the company from the Department of Defense, Department of Energy, National Science Foundation, and angel investors. Previously, Gus was a management consultant with the Boston Consulting Group. He received an M.B.A. from the University of Michigan Ross School of Business and a B.S. in mechanical engineering with honors from the University of Toledo.
Kathryn Stewart is a Board Advisor for the Dingman Center for Entrepreneurship at the Robert H. Smith School of Business at the University of Maryland. She is also Founder and Managing Director of Cranbrook Capital, which provides seed and early-stage capital to emerging tech-focused companies. The firm has invested in Apio Systems, CircleUp, Canvas, Homesnap, GoTenna, Passive Capital Management, and SalesWarp. Kathryn received her B.S. in electrical engineering from Michigan State University and her M.B.A. from the Wharton School, University of Pennsylvania.
Robert Storey is the Managing Director of The MVR Company, which focuses on the assessment and creation of new ventures, with a particular emphasis on medical technologies. He is also the Managing Partner of The LaunchPort™ in Baltimore, Maryland, an innovative manufacturing accelerator for companies entering the regulatory approval process and preparing for commercial adoption. He is Chairman and board member for a number of early-stage companies in orthopedics and cardiology.
Gil Tadmor is a highly respected industry leader, with more than 30 years of experience with software architecture, business intelligence and analytics, solution ideation and creation, agile systems development, cloud migration, and information technology (IT) systems modernization. Since joining DLH in 2015, he has led the company’s efforts in achieving Capability Maturity Model Integration certification, winning a G2X Federal Health IT Innovation Award, and redesigning and migrating a large-scale federal legacy health IT system. On a daily basis, he manages the company’s technology and innovation initiatives, emphasizing health IT, big data, and data analytics for current client programs and future growth opportunities. Prior to joining DLH, Gil served in technology leadership roles with SCI Group, Gene Logic, Corvis Corporation, and Raytheon. He has a master’s degree in computer science from Johns Hopkins University as well as a bachelor’s degree in mechanical engineering from The Technion, Israel’s Institute of Technology in Haifa.